United Therapeutics | UTHR - القيمة السوقية





القيمة السوقية تغيير تاريخ
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.48B 63M 2026-03
Baxter International USD 8.67B 1.15B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Insmed USD 35.3B 1.82B 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Moderna USD 20.15B 8.53B 2026-03
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03